Filter Options
Required*
Filter
New York / New York / United States
0.0
Pfizer, founded in 1849, is one of the largest research-based pharmaceuticals companies in the United States. The company s areas of expertise include human and animal health, and consumer health care products. Its human health segment offers medicines for cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye diseases and allergies. The consumer health care segment produces and markets various medications for oral care, upper respiratory and gastrointestinal health, tobacco dependence, skin and eye care, and hair growth. The company s animal health division develops products for the prevention and treatment of diseases in livestock and companion animals. The products offered by the division include parasiticides, anti-inflammatories, vaccines, and antibiotics. The company s well-known brands include Sudafed, Listerine, Benadryl, Lipitor, Diflucan, Zithromax, Viagra and Celebrex. It also produces pharmaceutical chemicals and gelatin capsules, and offers contract-manufacturing services. Pfizer has various subsidiaries, including Warner-Lambert, Parke-Davis, and Goedecke, and is headquartered in New York City.
New York / New York / United States
0.0
New York / New York / United States
0.0
Delcath Systems develops of perfusion technology for organ and region-specific delivery of therapeutic agents. The company s intellectual property portfolio consists of 12 patents on a worldwide basis, including the United States, Europe, Asia and Canada. Its primary objective is to establish the use of the Delcath system as the standard technique for delivering chemotherapy agents to the liver. Delcath Systems also performs research for the treatment of other liver diseases and cancers in other parts of the body. The company s staff features scientific advisors, technicians and managers. It is headquartered in Stamford, Conn.
New York / New York / United States
0.0
Immtech Pharmaceuticals is a pharmaceutical company that advances the development and commercialization of oral drugs to treat infectious diseases and extends its aromatic cation technology platform to the treatment of cancer, diabetes and other diseases. The company has clinical programs that include new treatments for malaria, pneumocystis pneumonia and African sleeping sickness, and drug development programs for fungal infections and tuberculosis. Immtech received worldwide patents and patent applications, and licenses and rights to license technology, primarily from a scientific consortium that has granted the company a worldwide license and rights to commercialize products from, and license rights to, the technology. The scientific consortium includes scientists from the University of North Carolina at Chapel Hill, Georgia State University, Duke University and Auburn University. Immtech Pharmaceuticals is headquartered in Vernon Hills, Ill.
New York / New York / United States
0.0
New York / New York / United States
0.0
Shop at CHEMDRUGSTORE for pain medications, OTC and so much more! You can also visit us to get your prescriptions filled. We work fast and we work accurately. Every minute and every penny you spend at CHEMDRUGSTORE will be worth it.
New York / New York / United States
0.0
Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Biosciences has leveraged the flexibility of its proven NexACT drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. Future growth is expected to be driven primarily through out-licensing of this technology for the development and commercialization of such compounds to pharmaceutical and biotechnology companies, worldwide. Concurrently, the company is seeking to monetize its existing product pipeline, including its approved drug erectile dysfunction treatment, Vitaros, as well as compounds in development from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer.
New York / New York / United States
0.0
New York / New York / United States
0.0
iBio, Inc. is a biopharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases. It has a pipeline of proprietary products in preclinical development, including sub-unit vaccines directed against both seasonal and pandemic influenza, sub-unit vaccines for prevention of anthrax and plague, sub-unit vaccines for treatment of HPV infections, therapeutic antibodies for treatment of anthrax and antibodies for prevention, treatment and diagnosis of pandemic influenza